All Q1 FY27 results →
DC

Devson Catalyst Ltd

Q1 FY27Chemicals & Petrochemicals

Devson Catalyst Q1 FY27 investor presentation: Revenue & Margins

Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.

Price₹370
Market cap₹503 Cr
P/E41.0
Updated18 Oct 2026
Read4 min read

Based on Devson Catalyst Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

The presentation does not provide explicit quarterly revenue or volume figures; data is reported annually for FY 2023-24, FY 2024-25, and FY 2025-26. The presentation provides annual financials, not specific quarterly EBITDA, operating margin, or PAT figures. - For FY 2025-26: - EBITDA reported as ₹1,676.46 lakhs - PAT reported as ₹1,252.09 lakhs - Operating margin (EBITDA margin) is 29.49% for FY 2025-26 (from Page 21).

From Devson Catalyst Ltd's Q1 FY27 earnings-call transcript · updated 18 Oct 2026.

Revenue & Sales Performance

  • The presentation does not provide explicit quarterly revenue or volume figures; data is reported annually for FY 2023-24, FY 2024-25, and FY 2025-26.
  • Annual Revenue from Operations:
  • FY 2023-24: ₹5,577.59 Lakhs
  • FY 2024-25: ₹5,319.21 Lakhs (4.63% decline YoY)
  • FY 2025-26: ₹4,346.99 Lakhs (18.29% decline YoY)
  • Product-wise revenue for FY 2025-26:
  • Catalyst: ₹2,792.62 Lakhs (50.56% of revenue)
  • Adsorbents: ₹599.18 Lakhs (10.85%)
  • Ceramic Balls: ₹2,131.18 Lakhs (38.59%)
  • Volume production capacity and utilization for FY 2025-26:
  • Installed capacity: 5,425.50 MTPA
  • Actual production: 5,011.40 MTPA (92.37% utilization)

2 more points from Devson Catalyst Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Devson Catalyst Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Current manufacturing facility: 7,737.30 Sq. Mtr. with installed capacity of 6,205 MTPA, ~86.83% utilization (Page 11, 15, 14).
  • Proposed capacity expansion: +5,088 MTPA, total planned capacity to reach 11,293 MTPA (Page 11, 15).
  • Proposed infrastructure expansion: +3,223 Sq. Mtr., total space to reach 10,960.30 Sq. Mtr. (Page 11, 15).
  • IPO proceeds’ primary object includes funding capital expenditure towards expansion of manufacturing facility: ₹1,739.84 lakhs mentioned (Page 28).

2 more points from Devson Catalyst Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Devson Catalyst Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly report any details related to order book, order inflow, or pending orders. There are no specific figures or statements about: - The current value or size of the order book. - The recent order inflow from customers. - Any pending or backlog of orders awaiting fulfillment. The presentation focuses on financials, manufacturing capacity, customer base, product portfolio, and IPO details but does not provide explicit data on order status.

Others in Chemicals & Petrochemicals this season

  • Thirumalai Chem. (Q1 FY27)

    Consolidated Revenue from Operations: INR 547 Cr (22% YoY increase from INR 450 Cr in Q1 FY26) . Key investor presentation takeaways from Thirumalai Chemicals L

  • Neochem Bio (Q1 FY27)

    Revenue from Operations in H2 FY26: ₹64.9 crore . Key investor presentation takeaways from Neochem Bio's Q1 FY27 investor presentation — and how it ranks agains

  • Lords Chloro (Q1 FY27)

    106.34 crore, a 6.88% YoY increase from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q1 FY27 investor presentation — and how it ranks

  • Prasol Chemicals (Q1 FY27)

    However, the company indicates strong demand with orders leading to capacity utilization rising from 12% to over 60% at the Mahad plant. Key concall takeaways…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Devson Catalyst Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Devson Catalyst Ltd Q1 FY27 results?

The presentation does not provide explicit quarterly revenue or volume figures; data is reported annually for FY 2023-24, FY 2024-25, and FY 2025-26. The presentation provides annual financials, not specific quarterly EBITDA, operating margin, or PAT figures. - For FY 2025-26: - EBITDA reported as ₹1,676.46 lakhs - PAT reported as ₹1,252.09 lakhs - Operating margin (EBITDA margin) is 29.49% for FY 2025-26 (from Page 21).

What is Devson Catalyst Ltd share price analysis?

Devson Catalyst Ltd currently shows a neutral. The stock trades at a P/E of 41.0 with a market cap of ₹503 Cr. Investors should review the full earnings analysis for detailed insights.

Is Devson Catalyst Ltd planning capital expenditure?

Current manufacturing facility: 7,737.30 Sq.

Keep Devson Catalyst Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.